The document describes the development of a new heptaplex PCR assay that can identify and differentiate Staphylococcus aureus and coagulase-negative staphylococci (CoNS), as well as detect various virulence factors and antibiotic resistance markers. The assay was tested on 255 staphylococcal strains, including 53 reference strains, 124 local clinical isolates, 31 CoNS isolates, and 47 non-staphylococcal bacterial isolates. The heptaplex PCR was able to detect 7 genetic markers (16S rRNA, spa, tuf, cns, pvl, mecA, vanA) and identify staphylococcal species and resistance profiles in under an hour
Emergence of ESBL worldwide has become a threat to successful treatment of noocomial infections. This deals with detection and treatment of ESBL infetions.
Emergence of ESBL worldwide has become a threat to successful treatment of noocomial infections. This deals with detection and treatment of ESBL infetions.
Presented by Dr. Jenkins at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
Gram-positive cocci include Staphylococcus (catalase-positive), which grows clusters, and Streptococcus (catalase-negative), which grows in chains. The staphylococci further subdivide into coagulase-positive (S. aureus) and coagulase-negative (S. epidermidis and S. saprophyticus) species. Streptococcus bacteria subdivide into Strep. pyogenes (Group A), Strep. agalactiae (Group B), enterococci (Group D), Strep viridans, and Strep pneumonia.
Gram-positive bacilli (rods) subdivide according to their ability to produce spores. Bacillus and Clostridia are spore-forming rods while Listeria and Corynebacterium are not. Spore-forming rods that produce spores can survive in environments for many years. Also, the branching filament rods encompass Nocardia and actinomyces.
Gram-positive organisms have a thicker peptidoglycan cell wall compared with gram-negative bacteria. It is a 20 to 80 nm thick polymer while the peptidoglycan layer of the gram-negative cell wall is 2 to 3 nm thick and covered with an outer lipid bilayer membrane.
Bloodstream infection mortality rates have increased by 78% in just two decades[1]. Gram-positive organisms have highly variable growth and resistance patterns. The SCOPE project (Surveillance and Control of Pathogens of Epidemiologic Importance) found that gram-positive organisms in those with an underlying malignancy accounted for 62% of all bloodstream infections in 1995 and 76% in 2000 while gram-negative organisms accounted for 22% and 14% of infections for these years.[2]
prof . dr. ihsan edan alsaimary
department of microbiology - college of medicine - university of basrah - basrah -IRAQ
ihsanalsaimary@gmail.com
00964 7801410838
Presented by Dr. Jenkins at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
Gram-positive cocci include Staphylococcus (catalase-positive), which grows clusters, and Streptococcus (catalase-negative), which grows in chains. The staphylococci further subdivide into coagulase-positive (S. aureus) and coagulase-negative (S. epidermidis and S. saprophyticus) species. Streptococcus bacteria subdivide into Strep. pyogenes (Group A), Strep. agalactiae (Group B), enterococci (Group D), Strep viridans, and Strep pneumonia.
Gram-positive bacilli (rods) subdivide according to their ability to produce spores. Bacillus and Clostridia are spore-forming rods while Listeria and Corynebacterium are not. Spore-forming rods that produce spores can survive in environments for many years. Also, the branching filament rods encompass Nocardia and actinomyces.
Gram-positive organisms have a thicker peptidoglycan cell wall compared with gram-negative bacteria. It is a 20 to 80 nm thick polymer while the peptidoglycan layer of the gram-negative cell wall is 2 to 3 nm thick and covered with an outer lipid bilayer membrane.
Bloodstream infection mortality rates have increased by 78% in just two decades[1]. Gram-positive organisms have highly variable growth and resistance patterns. The SCOPE project (Surveillance and Control of Pathogens of Epidemiologic Importance) found that gram-positive organisms in those with an underlying malignancy accounted for 62% of all bloodstream infections in 1995 and 76% in 2000 while gram-negative organisms accounted for 22% and 14% of infections for these years.[2]
prof . dr. ihsan edan alsaimary
department of microbiology - college of medicine - university of basrah - basrah -IRAQ
ihsanalsaimary@gmail.com
00964 7801410838
Bio303 laboratory diagnosis of infectionMark Pallen
In this Bio303 module talk, I provide an overview of how infections are diagnosed in the clinical microbiology lab, focusing on technologies, old and new, and also on practical issues and workflows crucial to optimal use of the lab.
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online
Candidia Species Commonly (Opportunistic human Pathogens)
C.albicans
C.glabata
C.guilliermandii
C.krusei
C.lusitaniae
C.parapsilosis
C.tropicalis
Candiia Species Uncommonly: 18 species
Alan Lesniewicz Memorial Lecture at UIC - July 2015Cassandra Quave
This is the keynote lecture given at the University of Illinois at Chicago Garden Walk event in the department of Pharmacognosy. The objectives of the talk were:
·Discuss the role of medical ethnobotany in drug discovery efforts
·Explore state-of-the-art research techniques that examine the activity of botanical natural products with next generation antibiotic discovery efforts focused on “alternative targets”, such as bacterial communication systems
·Provide examples of current research underway by her group both in the field (especially through fieldwork in the Mediterranean) and the lab (natural product research on multidrug resistant bacteria).
prof . dr. ihsan edan alsaimary
department of microbiology - college of medicine - university of basrah - basrah -IRAQ
ihsanalsaimary@gmail.com
00964 7801410838
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
2. INTRODUCTION
STAPHYLOCOCCUS
• Gram-positive cocci
• Spherical cells
• Arranged in clusters like “cluster
grapes”
• They grow rapidly on many types of
media and are metabolically active
Ferment carbohydrates
Produce pigments
3. • They are devoid of motility and not form spores.
• Facultative anaerobes: They can grow in aerobic or anaerobic form.
• Can be positive-coagulase ( Staphylococcus aureus) or negative-
coagulase (Staphylococcus epidermidis).
• Hydrogen peroxide H20 + O2
CATALASE
STREPTOCOCCUS
4. • The genus Staphylococcus contains at least 35 species and 17
subspecies. Three of importance are Staphylococcus aureus ,
Staphylococcus epidermidis , Staphylococcus saprophyticus .
• Cell wall: polysaccharides and antigenic proteins such as
peptidoglycan , teichoic acids, protein A.
• Can cause disease by their ability to multiply and spread extensively
in the tissues and by the production of many extracellular
substances (enzymes and toxins )
• Some are members of the normal flora of the skin and mucous
membranes of humans; others cause suppuration , abscess
formation , pyogenic infections or fatal septicemia.
5. GRAM STAINING
• GRAM-positive bacteria
• GRAM staining classified bacteria
based on the structure of their cell
walls.
• Purple stain due to its thick wall
peptidoglycan retaining the dye.
6. Staphylococcal lesions appear as grain , a hair follicle infection or
abscess
COMMON DISEASES
Intense
inflammatory
reaction
Drain pus Fibrin Cicatrization
Originate a broad spectrum of
systemic diseases that can
endanger life , infections of the
skin, soft tissues , bones and
genitourinary system and
opportunistic infections .
8. Staphylococcus aureus
Almost everyone
suffers from an
infection by this
bacterium in his
lifetime , ranging
from food
poisoning or
minor skin
infections to life-
threatening
severe skin
infections.
9. • Gram-positive cocci , positive catalase.
• Cause disease by producing toxin or through direct invasion and
tissue destruction
• Coagulase on the surface of the cell wall: binds to fibrinogen and
bacterial aggregation occurs
• Exposure to
contaminated
things.
• Direct contact
10. Risk factors
• Strange leather
(prostheses , catheters ).
• Previous surgery
• Antibiotics which suppress
the normal microbial flora
• Immunosuppressed
11. Virulence factors
Regulated by sensitive sistems to
environmental cues
Proteins
Kinase Response
regulator
Accessory gene regulator (agr ) is essential for
controlling gene expression
regulatory
functions in
gene
transcription
13. Low bacterial density
P2 promoter inactive
Transcript of
transmembrane proteins ,
AgrB , precursor peptide,
AgrD, AgrC y AgrA.
Increased bacterial
densities
AgrC
+
AgrA
+
P2 P3
Hemolisine δ
and RNAIII
transcription
surface expression of
adhesins
exoproteins secretation
14. Bacterial resistance
Quickly develop resistance to antibiotics after the introduction of penicillin
10% sensitive
PENICILASE Β lactamase hydrolyzes the β lactam
ring of penicillin
The genetic information
encoding the production
of this enzyme is a
transmissible plasmid
It facilitates the
rapid spread of
resistance among
Staphylococcus
15. Semisynthetic
penicillins
Resistant to hydrolysis
by β-lactamases
Methiciline
Nafcillin
Oxacillin
Dicloxacillin
Can also acquire
resistance to
these antibiotics
30- 50%
Methicillin-resistant
strains S. aureus are
included under the
acronym MRSA
16. Acquisition of resistance gene mecA
Encoding PBP2 protein
that binds to penicillin
• Penicillins and other lactam antibiotics
kill bacteria by their ability to bind
proteins binding to penicillin , which are
the enzymes responsible for building
wall peptide glycan
PBP2 protein does’nt bind to
penicillin , but maintains its
enzymatic activity
Heterogeneous
resistance
not all bacteria from a resistant
population expressing this protein
binding to penicillin
17. The only antibiotic that had kept
his uniform activity against
staphylococcus was vancomycin
Vancomycin resistance mechanisms
Low level resistance
Thickest and disorganized wall
vancomycin molecules are trapped in
the matrix of the cell wall and can’t
reach the cytoplasmic membrane , in
which alter the cell wall synthesis
High-level resistance
Encoded by the vanA gene operon
These bacteria have a modified
peptidoglycan layer that does’t fix
the molecules of vancomycin
18. PCR
• PCR-based assays are capable of identifying the genetic capacity for STAAR
(staphylococcal toxigenicity and antibiotic-resistance) without the influence of
variability in gene expression and are preferred for speed and sensitivity.
Multiplex PCR
assays
capable of detection of multiple
microbes or multiple genetic markers
within the same PCR tube
New heptaplex
PCR assay
Detected 7
DNA markers
16S rRNA
spa
tuf (genus Staphylococcus)
cns (CoNS)
pvl (PVL virulence
factor)mecAvanA
20. General purpose
Develop a new method of PCR assay to identify and differentiate
objectively virulence caused by staphylococcus aureus or CoNS and
mechanisms of antibiotic resistance.
21. Materiales y métodos
• La aprobación de bioética y bioseguridad de este estudio fue dada por el
Comité de investigación de la Universidad de Nottingham.
• Se utilizaron aislados bacterianos y hemocultivos de pacientes no
identificados para que no pudieran ser rastreados de nuevo.
• Muchas de las cepas bacterianas utilizadas en este estudio se obtuvieron de
la Red para la resistencia antibiótica de Staphylococcus aureus (NARSA ).
Algunos eran multi-resistentes o altamente virulentos
• Nivel 2 de bioseguridad: Para trabajo almacenamiento de agentes
potencialmente peligrosos
22. Cepas n= 255
• Sub-cultivadas y almacenados (-80 ° C)
en (BHI) y se sembraron en agar BHI.
Cultivos de
referencia
n= 53
Para validar los 7 marcadores
genéticos
Cepas estafilocócicas
locales
n= 124
Cepas CoNS n= 31
S. auricularis (2)
S capitis (2)
S. caprae (2)
S. chromogenes (2)
S. cohnii (2)
S. epidermidis (2)
S. hemolyticus (1)
S. hominis (2)
S. hyicus (2)
S. intermedius (2)
S. lugdunensis (1)
S. saprophyticus
(3)
S. sciuri (2)
S. simulans (2)
S. warneri (2)
S. xylosus (2)
23. Otras bacterias
no estafilococos
n= 47
Escherichia coli, Pseudomonas,
Klebsiella, Aeromonas, Salmonella,
Citrobacteria, Proteus, estreptococos
del grupo A (GAS).
24. NARSA (Network on Antimicrobial Resistance in Staphylococcus
aureus)
• Mantiene un depósito de cepas de Staphylococcus aureus y bacterias
relacionadas, que son importantes para el estudio de la resistencia
antibacteriana.
TRITON X-100: Lisis celular
Es un detergente no iónico usado para desnaturalizar membranas de células sin
desnaturalizar la proteína.
25. Brain Heart Infusion (BHI) Agar
PCR
Amplificar un gen o un fragmento específico de DNA en varios
millones de veces.
• Es un medio de uso general adecuado para el cultivo de una amplia variedad de
tipos de organismos (bacterias).
• Obtiene los nutrientes de la infusión de cerebro y corazón, la peptona y la
glucosa. Se utiliza fosfato disódico como tampón en el medio
26. Taq DNA polimerasa
• Es la enzima usada en el procedimiento de la PCR
• Producida por la bacteria termófila Thermus aquaticus.
• Enzima termoestable que no pierde su actividad a temperaturas elevadas
Termophol buffer
• Proporciona condiciones de reacción superiores para otras polimerasas
termófilas de ADN, incluyendo Taq ADN polimerasa, así como otros ADN y
enzimas modificadoras de ARN.
Electroforesis
método de laboratorio en el que se utiliza una corriente eléctrica
controlada, con la finalidad de separar biomoléculas según su
tamaño y carga eléctrica a través de una matriz gelatinosa.
27. GenElute™
Kit que contiene todos los reactivos necesarios para aislar y purificar ADN
genómico a partir de bacterias gram-negativas.
En esta investigación se usó para purificar los productos de PCR.
Prueba coagulasa tubo
Para diferenciar S. aureus de CoNS
31. Discussion
AUTHOR THEY SAID YES/ NO
Guembe M To circumvent this, the new heptaplex PCR assay
identifies all CoNS by detection of the cns marker.
Similarly, the detection of the 16S rRNA in all (100 %)
bacteria studied including staphylococcal and non-
staphylococcal strains supports the use of this gene as a
diagnostic marker for bacteria [43].
YES
Pichon B The 0.5 mg/L oxacillin used in this study supports the
recent report of low oxacillinresistant staphylococci (MIC
= 0.5 mg/L) in the UK [45].
NO
Geja DJ It has been suggested that mecA-positive staphylococci
showing low-level oxacillin-resistance should be
regarded as constitutively oxacillin-resistant [3].
YES
Hill R The new assay completes cycling within an hour which
compares favourably with a recent PVL/MRSA real-time
PCR assay [45].
NO
32. Conclusions
• The evolution of STAAR is such a relevant
adverse aspect in Public Health, antibiotic
threatments should take it as the main
target.
33. Conclusions
• Biomolecular studies most keep working
together with health studies, as it focus the
treatments to its more specific grade;
representing less adverse effects for
patients.
34. Conclusions
• The most effective ways of controling the
development of STAAR is making a
razonable use of antibiotics.
35. Conclusions
• Medical staff should try to make a good
diferencial diagnostic before starting any
antibiotic treatment, in order to dicrease
bio resistance development. That is why
the current assay used PCR heptaflex.
39. BIBLIOGRAFÍA
• Murray, P.R; Rosenthal K.S; Pfaller M.A. Staphylococcus y microorganismos
relacionados. Microbiología médica. Edición 5. Madrid, España: Elsevier;
2007. p. 221- 236
• Brooks, G.F; Carroll, K.C; Butel, J.S; Morse, S.A. Estafilococos.
Microbiología médica de Jawetz, Melnick y Adelberg. 19ª edición. México:
Manual Moderno, S.A; 2008. p.235- 241
40. BIBLIOGRAFÍA
• Clinical and Laboratory Standards Institute. Molecular Diagnostic Methods for
Infectious Diseases. Approved Guideline. Second Editionth ed. Wayne, PA:
Clinical and Laboratory Standards Institute; 2010. Document MM06-A2.
• Panda S, Kar S, Choudhury R, Sharma S, Singh DV. Development and
evaluation of hexaplex PCR for rapid detection of methicillin, cadmium/zinc
and antiseptic resistant staphylococci, with simultaneous identification of
PVL-positive and- negative Staphylococcus aureus and coagulase negative
staphylococci. FEMS Microbiol Lett. 2014;352(1):114–22.